Dieser Abschnitt ist nur in englischer Sprache verfügbar.

Notes to the financial statements of Sulzer Ltd

1 General information

– Financial reporting – Notes to the financial statements of Sulzer Ltd

1General information

Sulzer Ltd, Winterthur, Switzerland (the company), is the parent company of the Sulzer group. Its financial statements are prepared in accordance with Swiss law and serve as complementary information to the consolidated financial statements.

These financial statements were prepared according to the provisions of the Swiss Law on Accounting and Financial Reporting (32nd title of the Swiss Code of Obligations). Where not prescribed by law, the significant accounting and valuation principles applied are described below.

2 Key accounting policies and principles

2Key accounting policies and principles

Treasury shares

Treasury shares are recognized at acquisition cost and deducted from shareholders’ equity at the time of acquisition. In case of a resale, the gain or loss is recognized through the income statement as financial income or financial expenses.

Investments in subsidiaries and third parties

The participations are valued at acquisition cost or if the value is lower, at value in use, using generally accepted valuation principles.

Non-current interest-bearing liabilities

Non-current interest-bearing liabilities are recognized in the balance sheet at amortized cost. Discounts and issue costs for bonds are amortized on a straight-line basis over the bond’s maturity period.

Share-based payments

Sulzer Ltd operates a share-based payment program that covers the Board of Directors. Restricted share units (RSU) are granted annually. The plan features graded vesting over a three-year period. One RSU award is settled with one Sulzer share at the end of the vesting period. Awards automatically vest with the departure from the Board. The fair value of the Sulzer share at vesting date is recognized as compensation to the Board of Directors.

Foregoing a cash flow statement and additional disclosures in the notes

As Sulzer Ltd has prepared its consolidated financial statements in accordance with a recognized accounting standard (IFRS), it has decided to forego presenting additional information on audit fees and interest-bearing liabilities in the notes and a cash flow statement in accordance with the law.

3 Cash and cash equivalents

3Cash and cash equivalents

In 2021, the existing syndicated credit facility of CHF 500 million was renewed for a duration of five years until December 31, 2026. The facility includes two one-year extension options and a further option to increase the credit line by CHF 250 million (subject to lenders’ approval). The facility is subject to financial covenants based on net financial indebtedness and EBITDA of the Sulzer group, which were adhered to throughout the reporting period. As of December 31, 2021, and 2020, the syndicated facility was not used.

4 Investments in subsidiaries

4Investments in subsidiaries

A list of the major subsidiaries held directly or indirectly by Sulzer Ltd is included in note 36 to the consolidated financial statements.

On September 20, 2021, Sulzer Ltd shareholders at their Extraordinary General Meeting approved the proposed 100% spin-off of its Applicator Systems (APS) division (later renamed medmix) through a 1:1 share split, granting Sulzer shareholders one APS share in addition to each Sulzer share held. The spin-off was registered in the commercial registers of the cantons of Zurich and Zug on September 20, 2021, simultaneously with the incorporation of the new company, which was registered with a share capital 34’262’370 shares (registered shares with a nominal value of CHF 0.01 each). The spin-off became legally effective upon registration in the competent commercial registers, whereas the benefits and risks related to the assets and liabilities were economically transferred with retroactive effect as of January 1, 2021.

5 Equity

5Equity

Share capital

The share capital amounts to CHF 342’623.70, made up of 34’262’370 shares with dividend entitlement and a par value of CHF 0.01. All shares are fully paid in and registered.

Shareholders holding more than 3%

 

 

Dec 31, 2021

 

Dec 31, 2020

 

 

Number of shares

 

in %

 

Number of shares

 

in %

Viktor Vekselberg (direct shareholder: Tiwel Holding AG)

 

16’728’414

 

48.82

 

16’728’414

 

48.82

FIL Limited

 

1’114’854

 

3.25

 

-

 

-

Legal capital reserves and free reserves

As part of the spin-off of medmix from Sulzer Ltd by way of a 1:1 spin-off in accordance with article 29(b) and article 31(2)(a) Swiss Merger Act, Sulzer transferred total net assets amounting to CHF 344.3 million. The amount includes the net assets, as disclosed in the demerger balance sheet as of January 1, 2021, of CHF 423.6 million minus the unfulfilled part of an intercompany loan of CHF 80.2 million plus acquisition-related payments during 2021 of CHF 0.8 million. The intercompany loan represents the repayment and interest payment obligations under the loan agreement, which was transferred to medmix as part of the debt split as disclosed in the demerger plan dated May 27, 2021. The transferred net assets covered the amount of paid-in share capital of CHF 0.3 million, and the remainder was allocated to legal capital reserves (CHF 50.0 million) and free reserves (CHF 294.0 million).

Treasury shares held by Sulzer Ltd

 

 

2021

 

2020

millions of CHF

 

Number of shares

 

Total transaction amount

 

Number of shares

 

Total transaction amount

Balance as of January 1

 

426’467

 

38.3

 

240’924

 

25.6

Purchase

 

207’690

 

21.8

 

285’460

 

23.1

Share-based remuneration

 

–99’424

 

–9.1

 

–99’917

 

–10.4

Balance as of December 31

 

534’733

 

51.0

 

426’467

 

38.3

The total number of treasury shares held by Sulzer Ltd as of December 31, 2021, amounted to 534’733 (December 31, 2020: 426’467 shares), which are mainly held for the purpose of issuing shares under the management share-based payment programs.

6 Interest-bearing liabilities

6Interest-bearing liabilities

 

 

2021

 

2020

millions of CHF

 

Book value

 

Nominal

 

Book value

 

Nominal

0.375% 07/2016–07/2022

 

325.1

 

325.0

 

325.1

 

325.0

0.875% 07/2016–07/2026

 

125.0

 

125.0

 

125.0

 

125.0

1.300% 07/2018–07/2023

 

289.7

 

290.0

 

289.6

 

290.0

0.625% 10/2018–10/2021

 

 

 

209.9

 

210.0

1.600% 10/2018–10/2024

 

249.9

 

250.0

 

249.8

 

250.0

0.800% 09/2020–09/2025

 

299.5

 

300.0

 

299.3

 

300.0

0.875% 11/2020–11/2027

 

199.7

 

200.0

 

199.7

 

200.0

Total as of December 31

 

1’488.9

 

1’490.0

 

1’698.4

 

1’700.0

– thereof non-current

 

1’163.8

 

1’165.0

 

1’488.5

 

1’490.0

– thereof current

 

325.1

 

325.0

 

209.9

 

210.0

All the outstanding bonds are traded on SIX Swiss Exchange.

7 Contingent liabilities

7Contingent liabilities

millions of CHF

 

2021

 

2020

Guarantees, sureties and comfort letters for subsidiaries

 

 

 

 

– to banks and insurance companies

 

918.5

 

1’205.5

– to customers

 

198.8

 

214.6

– to others

 

483.0

 

436.8

Guarantees for third parties

 

42.9

 

11.0

Total contingent liabilities as of December 31

 

1’643.2

 

1’867.9

As of December 31, 2021, CHF 402.5 million (2020: CHF 295.5 million) in guarantees, sureties and comfort letters for subsidiaries to banks and insurance companies were utilized.

8 Administrative expenses

8Administrative expenses

millions of CHF

 

2021

 

2020

Compensation of Board of Directors

 

3.4

 

2.7

Other administrative expenses

 

86.6

 

59.0

Total administrative expenses

 

90.0

 

61.7

Sulzer Ltd does not have any employees. The compensation of the Board of Directors includes share-based payments and remuneration. Other administrative expenses contain management services and recharges from subsidiaries.

9 Investment income and investment and loan expenses

9Investment income and investment and loan expenses

In 2021, the investment income contained ordinary and extraordinary dividend payments from subsidiaries amounting to CHF 162.9 million (2020: CHF 159.0 million).

In 2021, Sulzer Ltd released hidden reserves in the amount of CHF 20.0 million (2020: CHF 30.0 million). 

The investment and loan expenses contain allowances on investments amounting to CHF 51.3 million (2020: CHF 2.1 million) and share of loss from associates amounting to CHF 2.0 million (2020: CHF 0.6 million).

10 Other income

10Other income

The income from trademark license amounts to CHF 42.3 million (2020: CHF 41.4 million).

11 Financial income and expenses

11Financial income and expenses

The financial income contains interests on loans with subsidiaries amounting to CHF 34.1 million (2020: CHF 35.2 million) and foreign currency valuation effects on loans amounting to CHF 9.1 million (2020: loss of CHF 48.5 million). The valuation on marketable securities from the medmix spin-off results in a gain of CHF 21.9 million (2020: CHF 0.0 million). The financial expenses contain mainly interest expenses on interest-bearing liabilities of CHF 15.9 million (2020: CHF 12.9 million).

12 Share participation of the Board of Directors, Executive Committee and related parties

12Share participation of the Board of Directors, Executive Committee and related parties

Restricted share units for members of the Board

The compensation of the Board of Directors consists of a fixed cash component and a restricted share unit (RSU) component with a fixed grant value. The number of RSU is determined by dividing the fixed grant value by the volume-weighted share price of the last ten days prior to the grant date. One-third of the RSU each vest after the first, second and third anniversaries of the grant date, respectively. Upon vesting, one vested RSU is converted into one share in Sulzer Ltd. The vesting period for RSU granted to the members of the Board of Directors ends no later than on the date on which the member steps down from the Board.

 

 

2021

 

 

Sulzer shares

 

Restricted share units (RSU) 1)

 

Performance share units (PSU) 2019 2)

 

Performance share units (PSU) 2020 3)

 

Performance share units (PSU) 2021 4)

Board of Directors

 

55’307

 

34’874

 

 

 

Peter Löscher

 

22’238

 

8’818

 

 

 

Suzanne Thoma

 

 

2’232

 

 

 

Matthias Bichsel

 

9’976

 

5’038

 

 

 

Mikhail Lifshitz

 

6’182

 

4’410

 

 

 

David Metzger

 

 

1’800

 

 

 

Alexey Moskov

 

639

 

3’756

 

 

 

Gerhard Roiss

 

14’413

 

4’410

 

 

 

Hanne Birgitte Breinbjerg Sørensen

 

1’859

 

4’410

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Executive Committee

 

77’941

 

 

81’932

 

94’735

 

49’936

Greg Poux-Guillaume

 

43’000

 

 

35’746

 

50’900

 

21’789

Daniel Bischofberger

 

9’720

 

 

9’932

 

9’427

 

6’053

Frederic Lalanne

 

6’797

 

 

9’932

 

9’427

 

6’053

Jill Lee

 

5’084

 

 

9’932

 

9’427

 

6’053

Armand Sohet

 

2’728

 

 

8’195

 

7’777

 

4’994

Torsten Wintergerste

 

10’612

 

 

8’195

 

7’777

 

4’994

1) Restricted share units assigned by Sulzer.

2) The average fair value of one performance share unit 2019 at grant date amounted to CHF 115.95.

3) The average fair value of one performance share unit 2020 at grant date amounted to CHF 78.18.

4) The average fair value of one performance share unit 2021 at grant date amounted to CHF 124.95.

 

 

2020

 

 

Sulzer shares

 

Restricted share units (RSU) 1)

 

Performance share units (PSU) 2018 2)

 

Performance share units (PSU) 2019 3)

 

Performance share units (PSU) 2020 4)

Board of Directors

 

56’020

 

27’510

 

 

 

Peter Löscher

 

19’437

 

6’210

 

 

 

Matthias Bichsel

 

8’238

 

3’853

 

 

 

Hanne Birgitte Breinbjerg Sørensen

 

816

 

3’106

 

 

 

Lukas Braunschweiler

 

1’097

 

3’106

 

 

 

Mikhail Lifshitz

 

4’781

 

3’106

 

 

 

Marco Musetti

 

8’639

 

3’106

 

 

 

Gerhard Roiss

 

13’012

 

3’106

 

 

 

Alexey Moskov

 

 

1’917

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Executive Committee

 

92’944

 

 

28’133

 

54’251

 

66’999

Greg Poux-Guillaume

 

58’062

 

 

12’820

 

23’363

 

33’267

Daniel Bischofberger

 

6’233

 

 

2’938

 

6’491

 

6’161

Frederic Lalanne

 

6’955

 

 

2’938

 

6’491

 

6’161

Jill Lee

 

7’945

 

 

3’561

 

6’491

 

6’161

Armand Sohet

 

6’624

 

 

2’938

 

5’355

 

5’083

Torsten Wintergerste

 

7’125

 

 

2’938

 

5’355

 

5’083

Girts Cimermans

 

 

 

 

705

 

5’083

1) Restricted share units assigned by Sulzer.

2) The average fair value of one performance share unit 2018 at grant date amounted to CHF 143.62.

3) The average fair value of one performance share unit 2019 at grant date amounted to CHF 115.95.

4) The average fair value of one performance share unit 2020 at grant date amounted to CHF 78.18.

Granted Sulzer shares to members of the Board of Directors

 

 

2021

 

2020

 

 

Quantity

 

Value in CHF

 

Quantity

 

Value in CHF

Allocated to members of the Board of Directors

 

16’632

 

1’155’000

 

17’715

 

1’155’000

13 Subsequent events after the balance sheet date

13Subsequent events after the balance sheet date

At the time when these financial statements were authorized for issue, the Board of Directors were not aware of any events that would materially affect these financial statements.